Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Autologous Mesenchymal Stem Cell Transplantation Via Liver Artery in Liver Cirrhosis Patients With Refractory Ascites

NCT01854125 is registered in ClinicalTrials.gov with Nanjing PLA General Hospital as lead sponsor.

NCT NCT01854125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01854125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Autologous Mesenchymal Stem Cell Transplantation Via Liver Artery in Liver Cirrhosis Patients With Refractory Ascites
Lead sponsor
Nanjing PLA General Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2013
Completion date
Not reported
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

characters of quality of life, child-pugh score, immune function in blood, liver function in blood, variation of ascites